The U.S. Food and Drug Administration on Friday gave its final go-ahead to the coronavirus vaccine developed by Pfizer and its German partner BioNTech. The move comes after an independent advisory board gave its approval on Thursday. The shot was the first coronavirus vaccine in the FDA’s approval pipeline. The agency could approve a version from Moderna Inc. next week and one from Johnson & Johnson early next year.
Health
New York Gov. Andrew Cuomo closed down indoor dining again starting Monday as the number of COVID-19 cases begin to climb faster after Thanksgiving. Some expect the U.S. Food and Drug Administration to grant emergency use authorization to Pfizer’s COVID-19 vaccine as soon as Saturday after a panel of advisers gave the thumbs up on Thursday. One of the four members of the panel who voted no, Dr.
A group of independent advisers voted 17-4, with one abstention, to endorse the first U.S. coronavirus vaccine on Thursday. The panel said the shot from Pfizer and its German partner BioNTech appears safe and effective for people age 16 and up.
Most Popular

Measuring health guesses
Medicine | Don't assume the healthcare industry has it all right